Literature DB >> 8378352

A model for tumor suppression using H-1 parvovirus.

A Telerman1, M Tuynder, T Dupressoir, B Robaye, F Sigaux, E Shaulian, M Oren, J Rommelaere, R Amson.   

Abstract

A model system is proposed to investigate, at the molecular level, the pathways of tumor suppression. As a tool for the selection of cells with a suppressed phenotype, we used the H-1 parvovirus that preferentially kills various neoplastic cells. From the human K562 leukemia cells, we isolated a clone, KS, that is resistant to the cytopathic effect of the H-1 virus and displays a suppressed malignant phenotype. The suppressed malignancy and the cellular resistance to H-1 killing appear to depend on the activity of wild-type p53. Whereas the KS cells express wild-type p53, the protein is undetectable in the parental K562 cells. Experiments with p53 mutants suggest that wild-type p53, in its functionally intact state, contributes to the resistance against the cytopathic effect of H-1 parvovirus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8378352      PMCID: PMC47426          DOI: 10.1073/pnas.90.18.8702

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression.

Authors:  B E Weissman; P J Saxon; S R Pasquale; G R Jones; A G Geiser; E J Stanbridge
Journal:  Science       Date:  1987-04-10       Impact factor: 47.728

2.  Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes.

Authors:  M Noda; H Kitayama; T Matsuzaki; Y Sugimoto; H Okayama; R H Bassin; Y Ikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 3.  The autonomously replicating parvoviruses of vertebrates.

Authors:  S F Cotmore; P Tattersall
Journal:  Adv Virus Res       Date:  1987       Impact factor: 9.937

4.  Revertants of v-fos-transformed fibroblasts have mutations in cellular genes essential for transformation by other oncogenes.

Authors:  H Zarbl; J Latreille; P Jolicoeur
Journal:  Cell       Date:  1987-11-06       Impact factor: 41.582

5.  Suppression of malignancy by cell fusion.

Authors:  H Harris; O J Miller; G Klein; P Worst; T Tachibana
Journal:  Nature       Date:  1969-07-26       Impact factor: 49.962

6.  A sequence in M13 phage detects hypervariable minisatellites in human and animal DNA.

Authors:  G Vassart; M Georges; R Monsieur; H Brocas; A S Lequarre; D Christophe
Journal:  Science       Date:  1987-02-06       Impact factor: 47.728

Review 7.  Antineoplastic activity of parvoviruses.

Authors:  J Rommelaere; J J Cornelis
Journal:  J Virol Methods       Date:  1991-08       Impact factor: 2.014

8.  Flat revertants isolated from Kirsten sarcoma virus-transformed cells are resistant to the action of specific oncogenes.

Authors:  M Noda; Z Selinger; E M Scolnick; R H Bassin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

9.  Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells.

Authors:  H J Huang; J K Yee; J Y Shew; P L Chen; R Bookstein; T Friedmann; E Y Lee; W H Lee
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

10.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma.

Authors:  S H Friend; R Bernards; S Rogelj; R A Weinberg; J M Rapaport; D M Albert; T P Dryja
Journal:  Nature       Date:  1986 Oct 16-22       Impact factor: 49.962

View more
  25 in total

1.  Parvovirus nonstructural proteins induce an epigenetic modification through histone acetylation in host genes and revert tumor malignancy to benignancy.

Authors:  Hiroyoshi Iseki; Rie Shimizukawa; Fumihiro Sugiyama; Satoshi Kunita; Atsushi Iwama; Masafumi Onodera; Hiromitsu Nakauchi; Ken-ichi Yagami
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  SIAH-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding, and trafficking: identification of common effectors with p53 and p21(Waf1).

Authors:  J P Roperch; F Lethrone; S Prieur; L Piouffre; D Israeli; M Tuynder; M Nemani; P Pasturaud; M C Gendron; J Dausset; M Oren; R B Amson; A Telerman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

3.  Translation control by protein kinase R restricts minute virus of mice infection: role in parvovirus oncolysis.

Authors:  Iván Ventoso; Juan J Berlanga; José M Almendral
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

4.  Genome replication and postencapsidation functions mapping to the nonstructural gene restrict the host range of a murine parvovirus in human cells.

Authors:  M P Rubio; S Guerra; J M Almendral
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  B1 lymphocytes and myeloid dendritic cells in lymphoid organs are preferential extratumoral sites of parvovirus minute virus of mice prototype strain expression.

Authors:  Zahari Raykov; Larissa Savelyeva; Ginette Balboni; Thomas Giese; Jean Rommelaere; Nathalia A Giese
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

6.  Translationally controlled tumor protein is a target of tumor reversion.

Authors:  Marcel Tuynder; Giusy Fiucci; Sylvie Prieur; Alexandra Lespagnol; Anne Géant; Séverine Beaucourt; Dominique Duflaut; Stéphanie Besse; Laurent Susini; Jean Cavarelli; Dino Moras; Robert Amson; Adam Telerman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-15       Impact factor: 11.205

7.  Down-regulation of inwardly rectifying Kir2.1 K+ channels by human parvovirus B19 capsid protein VP1.

Authors:  Musaab Ahmed; Bernat Elvira; Ahmad Almilaji; C-Thomas Bock; Reinhard Kandolf; Florian Lang
Journal:  J Membr Biol       Date:  2014-12-09       Impact factor: 1.843

Review 8.  The molecular programme of tumour reversion: the steps beyond malignant transformation.

Authors:  Adam Telerman; Robert Amson
Journal:  Nat Rev Cancer       Date:  2009-01-30       Impact factor: 60.716

9.  Viral oncolysis that targets Raf-1 signaling control of nuclear transport.

Authors:  Laura Riolobos; Noelia Valle; Eva Hernando; Beatriz Maroto; Michael Kann; José M Almendral
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

10.  Killing of p53-deficient hepatoma cells by parvovirus H-1 and chemotherapeutics requires promyelocytic leukemia protein.

Authors:  Maike Sieben; Kerstin Herzer; Maja Zeidler; Vera Heinrichs; Barbara Leuchs; Martin Schuler; Jan-J Cornelis; Peter-R Galle; Jean Rommelaere; Markus Moehler
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.